Showing results (1831-1840 of 2,432) with videos related to

Sort By:
Pageof 244
Biorxiv : the Preprint Server for Biology|February 6, 2026
Scattering-enabled epi-quantitative phase imaging reveals subcellular detail in organoids and deep mouse brainsXi Chen, Mikhail E Kandel, Shitong Zhao, et al.
Frontiers in Neuroscience|October 23, 2023
Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behaviorChrista Corley, Taylor McElroy, Bhavana Sridharan, et al.
Cancer Biology & Therapy|August 13, 2002
Apoptosis inhibitor as a suppressor of tumor progression: expression of Bcl-2 eliminates selective advantages for p53-deficient cells in the tumorKaterina V Gurova, Serena S S Kwek, Igor E Koman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 10, 2019
A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung CancerP Munoz-Schuffenegger, S Kandel, Z Alibhai, et al.
Journal of Pediatric Surgery|June 8, 1999
Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumorM L Kayton, D H Rowe, K M O'Toole, et al.
Cell|December 15, 1995
Aplysia CREB2 represses long-term facilitation: relief of repression converts transient facilitation into long-term functional and structural changeD Bartsch, M Ghirardi, P A Skehel, et al.
Behavioral Neuroscience|July 29, 2009
Impaired timing precision produced by striatal D2 receptor overexpression is mediated by cognitive and motivational deficitsRyan D Ward, Christoph Kellendonk, Eleanor H Simpson, et al.
Molecular Carcinogenesis|October 2, 2019
The role of polo-like kinase 3 in the response of BRAF-mutant cells to targeted anticancer therapiesMahamat Babagana, Julia V Kichina, Hannah Slabodkin, et al.
Cornea|June 24, 2024
Intereye Asymmetry as a Predictor of Progression in Patients With Untreated Keratoconus: Findings From a Longitudinal StudyFrancisco Arnalich-Montiel, Sara Ortiz-Toquero, Himal Kandel, et al.
Plos One|May 23, 2012
Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1Jaydip Das Gupta, Ka-Cheung Luk, Ning Tang, et al.
Pageof 244